Patent Applications in U.S. and Europe

Welcome to the Bioasis Technologies Hub On AGORACOM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10493 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Patent Applications in U.S. and Europe

posted on Jun 24, 2019 04:20PM

TSXV's Bioasis Near 52 Week Lows As Announces Allowances of Patent Applications in U.S. and Europe

04:15 PM EDT, 06/24/2019 (MT Newswires) -- Bioasis Technologies Inc. (BTI.V; OTCQB:BIOAF) , a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier and the treatment of central nervous system disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, announced after close of trade Monday that the U.S. Patent and Trademark Office and the European Patent Office have issued allowances of patent applications relating to xB3 technology.